³Ô¹ÏÍøÕ¾

Latest cell therapy News

Support for state-of-the-art cancer research projects
KI Research Presented To Eleven Nobel Laureates
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
Swedish Cancer Society grants SEK 23 million to MedH researchers
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
New study on microRNAs could lead to better fertility treatment
Stem cell therapy reverses type 1 diabetes in world first
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
Help Shape Future Of Bone Marrow Transplants
Chimeric announces new collaboration with Achieve Clinics
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing
Magellan Stem Cells welcomes $7m Australian Government grant
Balzan Prize 2024 For Lorraine Daston
New approach moves cell therapy closer to treating many disorders
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
New Treatment Hope For Perinatal Lung And Brain Injury
Baylor College of Medicine receives more than $17 million from CPRIT
Miles Government Unveils Queensland Cancer Plan
Chimeric Therapeutics says first patient enrolled in cell therapy trial
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
New Strategy Can Improve Cell Therapy Against Cancer
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
Research Funding For Ovarian Cancer Treatment
ACTION Centre to boost access to life-saving new therapies for children
AI Predicts Tumor-killing Cells With High Accuracy
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
Immune networks in tumors prime responses to a personalized immunotherapy
Arovella licences novel CARiNKT cell armouring technology
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson’s Disease Patients Worldwide in Japan
Unlocking power of immune system to kill prostate cancer
Preventing Exhaustion of T Cells
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Dan L Duncan Comprehensive Cancer Center to open cell therapy clinical trials at Harris Health
Viralgen welcomes back Andy Holt as CCO
Victoria backing Australia’s first stem cell trial for rare genetic disorder
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Cerebral palsy community consulted over stem cell treatment
Researchers combat Zika-associated fetal abnormalities using microRNA
Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
Nanoneedle breakthrough gives hope for cheaper cancer treatment
Imugene licenses allogeneic CAR-T with a potential registration study in 2024